Table 2.
Number of subjects experienced adverse reactions within 28 d of vaccination.
| Leprosy cured group (n = 41) | Control group (n = 24) | |||
| Variables | Male | Female | Male | Female |
| Solicited injection-sites adverse events | ||||
| Subtotal∗ | 0 | 0 | 3 | 4 |
| Pain | 0 | 0 | 1 | 0 |
| Itching | 0 | 0 | 2 | 3 |
| Erythema | 0 | 0 | 1 | 0 |
| Swelling | 0 | 0 | 0 | 1 |
| Induration | 0 | 0 | 0 | 1 |
| Ecchymosis | 0 | 0 | 0 | 0 |
| Solicited systemic adverse events | ||||
| Subtotal∗ | 0 | 0 | 2 | 5 |
| Fever | 0 | 0 | 1 | 3 |
| Malaise | 0 | 0 | 0 | 1 |
| Headache | 0 | 0 | 1 | 1 |
| Myalgia | 0 | 0 | 0 | 0 |
| Vomiting | 0 | 0 | 0 | 0 |
| Diarrhea | 0 | 0 | 0 | 0 |
| Shivering | 0 | 0 | 0 | 0 |
| Total∗ | 0 | 0 | 3 | 6 |